A REVIEW OF OZEMPIC’S OFF LABEL USE FOR WEIGHT LOSS IN NON-DIABETIC INDIVIDUALS: CLINICAL EVIDENCE, SAFETY AND ETHICS. (2026). Bioscience Insights, 3(3), 48-53. https://www.biosciinsights.com/index.php/BI/article/view/188